Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer.
Elisabeth WadenstenSandra WessmanFrida AbelTeresita Díaz de StåhlBianca TesiChristina Orsmark PietrasLinda ArvidssonFulya TaylanSusanne FranssonHartmut VogtAnna PoluhaSailendra PradhanangaMaria HellbergKristina Lagerstedt-RobinsonPraveen Raj SomarajanSofie SamuelssonSara OrrsjöKhurram MaqboolKarin HenningTobias StridTorben EkHenrik FagmanThomas Olsson BontellTommy MartinssonFlorian PulsPer KognerValtteri WirtaCornelis J H PronkJoakim WilleRichard RosenquistMonica NistérFredrik MertensMagnus SabelUlrika Norén-NyströmPernilla GrillnerAnn NordgrenGustaf LjungmanJohanna SandgrenDavid Gisselssonnull nullPublished in: JCO precision oncology (2023)
Up-front, large-scale genomic characterization of pediatric solid malignancies provides diagnostically valuable data in the majority of patients also in a largely unselected cohort.